News
All News
Publications
All PublicationsPharmTechPharmTech Europe
Multimedia
All VideosAsk the ExpertBehind The HeadlinesDrug Digest VideosDrug Solutions Podcast
Conferences
Conference CoverageConference Listing
More
Webcasts
Resources
ICH Q9 Revision: A Comprehensive Resource on Quality Risk ManagementPartnersPeer-Reviewed ResearchPharmTech ProductsPharma InsightsSponsored PodcastsSponsored VideosSponsored eBooksState of the ScienceWhitepapers

Subscribe

  • News
  • Publications
  • Multimedia
  • Conferences
  • Webcasts
  • Resources
  • Subscribe
  • Analytics
    • Bio/Pharmaceutical Analysis Techniques
    • Laboratory Equipment and Instruments
  • Data and Artificial Intelligence
  • Dosage Forms
    • Solid/Semi-Solid Dosage
    • Specialty Dosage Drugs
    • Parenterals and Injectables
    • Inhalation Drugs
  • Drug Development
    • Intellectual Property and Patents
    • Process and Scaling
    • APIs and Excipients
    • Ingredients
    • Formulation and Drug Delivery
  • Manufacturing
    • Aseptic/Sterile Processing
    • Equipment
    • Process and Automation
    • Manufacturing, Parenterals and Injectables
    • Manufacturing, Biosimilars and Biobetters
    • Manufacturing, Inhalation Drugs
    • Manufacturing, Solid and Semi-Solid Dosage Drugs
    • Manufacturing, Cell Therapies
    • Manufacturing, Biologic Drugs
    • Supply Chain
    • Manufacturing, Gene Therapies
    • Packaging and Distribution
  • Outsourcing
    • Contract Research Services
    • Contract Analytical Services
    • Contract Development Services
    • Regulatory Consulting
    • Logistics and Distribution
    • Contract Manufacturing Services
  • Quality Systems
    • Ask the Expert
    • Quality Assurance/Quality Control
    • Regulatory Oversight and Compliance
Spotlight -
Analytics|
Dosage Forms|
Drug Development|
Manufacturing|
Outsourcing|
Quality Systems
Advertisement
|Articles|April 3, 2023

Syngene Utilizes New Innovation in the Manufacturing Value Chain

Author(s)Jill Murphy
Advertisement

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Advertisement

Related Content

Advertisement
Cellares Secures $257M | Created with Canva

Cellares Secures $257M to Scale Global Cell Therapy Manufacturing

ByChristopher Cole
January 29th 2026
Nerve cell with blue background attacked by red antibodies - 3D illustration of autoimmune disease | Image Source: ©peterschreiber.media -stock.adobe.com

Repertoire Immune Medicines and Lilly Collaborate on Treatments for Autoimmune Diseases

BySusan Haigney
January 29th 2026
Laine Mello, Ecolab

Leveraging Next-Gen Therapies, Advanced Purification, and Strategic Collaborations in Pharma Production

BySusan Haigney,Zachary Zubulake
January 26th 2026
Laine Mello, Ecolab

Integrating AI Discovery, Continuous Manufacturing, and Modern Regulatory Hurdles into Pharma Production

BySusan Haigney
January 23rd 2026
Young woman after chemotherapy taking pills from nurse in hospital room. Brain cancer concept | Image Credit: ©Pixel-Shot -stock.adobe.com

The Impact of Patient-Centric Formulations on Service Providers

BySusan Haigney
January 16th 2026
Advertisement
Advertisement

Trending on Pharmaceutical Technology

1

US Withdrawal From WHO Creates New Pharma Logistics Vulnerabilities

2

Securing Radiopharma and GLP-1 Supply Chains Through 2026 M&A

3

Lilly Invests $3.5B in Pennsylvania Injectable Medicine Facility

4

Halo Pharma Becomes Dedicated North American Drug Product CDMO

5

Repertoire Immune Medicines and Lilly Collaborate on Treatments for Autoimmune Diseases

  • About Us
  • Advertise
  • Contact Us
  • Editorial Info
  • Editorial Advisory Board
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us